Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Orchestra BioMed Holdings (OBIO) Operating Expenses: 2022-2024

Historic Operating Expenses for Orchestra BioMed Holdings (OBIO) over the last 3 years, with Dec 2024 value amounting to $66.9 million.

  • Orchestra BioMed Holdings' Operating Expenses rose 22.19% to $21.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $78.1 million, marking a year-over-year increase of 24.39%. This contributed to the annual value of $66.9 million for FY2024, which is 23.35% up from last year.
  • Orchestra BioMed Holdings' Operating Expenses amounted to $66.9 million in FY2024, which was up 23.35% from $54.3 million recorded in FY2023.
  • Orchestra BioMed Holdings' Operating Expenses' 5-year high stood at $66.9 million during FY2024, with a 5-year trough of $36.2 million in FY2022.
  • Its 3-year average for Operating Expenses is $52.5 million, with a median of $54.3 million in 2023.
  • Data for Orchestra BioMed Holdings' Operating Expenses shows a peak YoY skyrocketed of 49.95% (in 2023) over the last 5 years.
  • Yearly analysis of 3 years shows Orchestra BioMed Holdings' Operating Expenses stood at $36.2 million in 2022, then surged by 49.95% to $54.3 million in 2023, then rose by 23.35% to $66.9 million in 2024.